Tahereh Jamshidi, MD
Rheumatology Physician in Washington, District of Columbia.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 6,200 in Rheumatology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Tahereh Jamshidi, MD filed 376 Medicare Part D claims in 2023 as a Rheumatology Physician in Washington, District of Columbia, prescribing 72% generic.
- 376
- Part D claims, 2023
- 72%
- generic prescribing
- $2.8K
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Tahereh Jamshidi, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
376 Top 43% higher than 57% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
Tahereh Jamshidi, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Tahereh Jamshidi, MD?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in District of Columbia
How Rheumatology Physician compares to other specialties among District of Columbia providers
Rheumatology Physician ranks #97 among District of Columbia's specialties (0.1% of in-state providers)
Each bar is a specialty's share of the District of Columbia provider total, by primary NUCC taxonomy. The highlighted bar is Rheumatology Physician; the long tail of smaller specialties is omitted for legibility.
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Rheumatology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Tahereh Jamshidi, MD appears in the CMS NPPES registry as a Rheumatology Physician provider holding MD credentials at 2041 GEORGIA AVE NW TOWER 5100, Washington, DC, 20060, with a listed phone of (202) 865-3290. NPI 1225201916 was issued on 04/02/2008.
Medicare Part D records for calendar year 2023 show 376 prescription claims written by this provider, covering 85 Medicare beneficiaries and totaling roughly $917K in drug spend, split 28% brand-name and 72% generic by claim count, with an opioid prescribing rate of 10.4%.
Rheumatology Physician is a mid-sized specialty nationwide, with 6,200 enrolled providers across 52 states and an average of 2,054 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1225201916 |
|---|---|
| Specialty | Rheumatology Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 04/02/2008 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Tahereh Jamshidi, MD's current license status, disciplinary history, and board certifications with the D.C. Board of Medicine in District of Columbia before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1225201916 is the unique 10-digit identifier CMS uses to link Jamshidi across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Tahereh Jamshidi, MD. Source: openpaymentsdata.cms.gov.
Total received
$2.8K
Largest payer
SOBI, INC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
28% brand-name claims vs 72% generic, on 376 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 616
- Total Day Supply
- 17,582
- Brand vs Generic
- 28% brand / 72% generic
- Brand Drug Cost
- $910K
- Generic Drug Cost
- $7K
- Opioid Claims
- 39 (10.4% rate)
Patient Demographics
- Average Patient Age
- 69.2 years
- Avg HCC Risk Score
- 1.80
- Gender Split
- 80% female / 20% male
- Age Distribution
- <65: 21, 65-74: 39, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Tahereh Jamshidi, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Methotrexate
Methotrexate
62 claims
- Hydroxychloroquine…
Hydroxychloroquine Sulfate
34 claims
- Acetaminophen-Code…
Acetaminophen-Codeine
30 claims
- Allopurinol
Allopurinol
28 claims
- Prednisone 24
Prednisone
24 claims
- Humira Pen 16
Humira Pen
16 claims
- Benlysta 15
Benlysta
15 claims
- Actemra 14
Actemra
14 claims
| Drug | Claims |
|---|---|
| Methotrexate Methotrexate Sodium | 62 |
| Hydroxychloroquine Sulfate | 34 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 30 |
| Allopurinol | 28 |
| Prednisone | 24 |
| Humira Pen Adalimumab | 16 |
| Benlysta Belimumab | 15 |
| Actemra Tocilizumab | 14 |
| Diclofenac Sodium | 14 |
| Humira(Cf) Pen Adalimumab | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Rheumatology Physician Overview
How Tahereh Jamshidi, MD fits within the Rheumatology Physician landscape nationally.
Tahereh Jamshidi, MD's 376 claims are below the specialty average of 2,054.
Nearby Rheumatology Physician Providers in District of Columbia
Other clinicians with the same primary specialty enrolled in District of Columbia, drawn from the same CMS NPPES roster as Jamshidi.
Compare Rheumatology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the District of Columbia medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Rheumatology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore District of Columbia
Frequently Asked Questions
What is Tahereh Jamshidi, MD's specialty? ▼
How much does Tahereh Jamshidi, MD prescribe under Medicare Part D? ▼
Where is Tahereh Jamshidi, MD located? ▼
What is Tahereh Jamshidi, MD's NPI number? ▼
Does Tahereh Jamshidi, MD prescribe more brand-name or generic drugs? ▼
Does Tahereh Jamshidi, MD prescribe opioids? ▼
How many Rheumatology Physician providers are there in the US? ▼
What drugs does Tahereh Jamshidi, MD prescribe most often? ▼
Does Tahereh Jamshidi, MD accept Medicare? ▼
How can I verify Tahereh Jamshidi, MD's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor Editorial
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.